Haleon (HLN) Debt Ratio (2021 - 2025)

Haleon (HLN) recorded quarterly Debt Ratio of 0.26 in Q4 2025, up 2.68% on a QoQ basis from 0.26 in Q4 2024, and up 2.68% year-over-year from 0.26 in Q4 2024.

Haleon (HLN) Debt Ratio (2021 - 2025) Analysis & Trends

Haleon has disclosed Debt Ratio across 5 years of filings, most recently posting 0.26 for Q4 2025.

  • Quarterly Debt Ratio rose 2.68% year-over-year to 0.26 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.26 (up 2.68% YoY) and the FY2025 annual result came in at 0.26, up 2.68% from the prior year.
  • Debt Ratio grew to 0.26 in Q4 2025, from 0.26 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.3 in Q4 2022 and troughed at 0.28 in Q2 2023.
  • A 5-year average of 0.09 and a median of 0.26 in 2024 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio surged 6123.4% — and 2023, when it sank 42.0%.
  • Tracing HLN's Debt Ratio over 5 years: stood at 0.0 in 2021, then jumped by 6123.4% to 0.3 in 2022, then fell by 7.4% to 0.28 in 2023, then retreated by 7.46% to 0.26 in 2024, then grew by 2.68% to 0.26 in 2025.
  • Business Quant data shows HLN's Debt Ratio at 0.26 in Q4 2025, 0.26 in Q4 2024, and 0.28 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.42
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.60
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.30
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.35
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.24
10 Haleon 1.09 Bn -773.69 Mn - 0.26

Historic Data

Download Data
DateValue
Dec 31, 2025 0.26
Dec 31, 2024 0.26
Dec 31, 2023 0.28
Jun 30, 2023 -0.28
Dec 31, 2022 0.30
Jun 30, 2022 -0.20
Dec 31, 2021 0.00